JPRN-UMIN000003476招募中2 期
Phase II study of Weekly Paclitaxel+Weekly Carboplatin for Platinum/Taxan sensitive recurrent mullerian carcinoma - Phase II study of Platinum/Taxan sensitive recurrent mullerian carcinoma
Japan Kanto Tumor Board(JKTB)0 个研究点目标入组 65 人开始时间: 2010年4月12日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 65
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.Progression free interval<6months 2.Prior chemotherapy>2regimen 3.Pleural effusion need to continued drainage. 4.Evidense of severe or uncontrolled cardiac disease. 5.Hystory of myocardial infarction within 6months. 6.Hystory of cirrhosis or active hepatitis. 7.Severe plumonary disease(interstitial pneumonia,pulmonary fibrosis,)8.Gastrointestinal bleeding that requires iteration transfusion. 9.Serius psychological disease. 10.Uncontrolled diabetes. 11.Bowel obstruction. 12.Infection with fever. 13.Active double carcinoma. 14.Symptomatic brain metastasis. 15.Accute inflammatory desease. 16.Sevre peripheral neuropathy. 17.Patients with any history of serious drug reactions 18.History of hyper sensitivity to polyoxyethylene castor oil(ChremophorEL) or contained castor oil(vitamin injection) 19.Pregnant or lactating woman. 20.Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator.
研究者
相似试验
已完成
不适用
Phase I/II Study of Weekly Paclitaxel and Carboplatin with Concurrent Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer. Kansai Clinical Oncology Group KCOG T-0401ocally Advanced Non-Small-Cell Lung CancerJPRN-UMIN000026606Kansai Clinical Oncology Group40
已完成
1 期
A Phase I Study of Weekly Nab-Paclitaxel/Carboplatin in Chemotherapy-Naive Patients with Advanced Non-Small-Cell Lung Cancerpreviously untreated advanced non-small cell lung cancerJPRN-UMIN000012788Department of Respiratory Medicine in Hyogo Prefectural Amagasaki Hospital30
已完成
2 期
The prospective study of weekly Paclitaxel and Carboplatin for elderly patients with gynecologic cancerPatients older than 75 years old with gynecologic cancer who are administered Paclitaxel and CarboplatinJPRN-UMIN000028336Obsterics and Gynecology in Osaka Medical College30
招募中
2 期
A Phase II study of Paclitaxel plus Carboplatin plus Bevacizumab that introduces concept of Clinical PD in recurrent or advanced non-squamous non-small cell lung cancer.recurrent or advanced non-squamous non-small-cell and lung cancer.JPRN-UMIN000005328Dept. of Respiratory Medicine, Osaka University Hospital45
已完成
2 期
Phase II study of Carboplatin, weekly Paclitaxel and Bevacizumab in elderly patients with advanced non-squamous non-small-cell lung cancer (NEJ 016)non-small cell lung cancerJPRN-UMIN000006622orth East Japan Study Group36